Mer­ck KGaA’s Mil­li­pore­Sig­ma in­vests $286M to build out biosafe­ty test­ing

Mil­li­pore­Sig­ma, the US and Cana­di­an life sci­ence di­vi­sion of Mer­ck KGaA, is plunk­ing down al­most $300 mil­lion to boost biosafe­ty test­ing in the US.

The com­pa­ny said it will in­vest $286 mil­lion to bulk up biosafe­ty test­ing at its man­u­fac­tur­ing site in Rockville, MD. The new, 250,000-square-foot fa­cil­i­ty ex­pan­sion will ex­tend its ca­pac­i­ty for biosafe­ty test­ing, an­a­lyt­i­cal de­vel­op­ment, vi­ral clear­ance suites and ser­vices for cell bank man­u­fac­tur­ing. Mil­li­pore­Sig­ma didn’t de­tail project time­line in its an­nounce­ment and did not re­spond­ed to a re­quest for com­ment from End­points News by press time.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER